Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative Radiotherapy vs TACE in Hepatocellular Carcinoma
NCT02678806Unknown
- Sponsor
- Guangxi Medical University
- Start
- Nov 2017
- Primary completion
- Nov 2018
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Guangxi Medical University. Primary endpoint: Overall Survival at 5 years. Status: unknown.
Beyond the preview
Go deeper on NCT02678806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02678806.